AU3343078A - PROCESS FOR PRODUCING (d. 1)-5-METHYL-TETRAHYDROFOLIC ACID - Google Patents

PROCESS FOR PRODUCING (d. 1)-5-METHYL-TETRAHYDROFOLIC ACID

Info

Publication number
AU3343078A
AU3343078A AU33430/78A AU3343078A AU3343078A AU 3343078 A AU3343078 A AU 3343078A AU 33430/78 A AU33430/78 A AU 33430/78A AU 3343078 A AU3343078 A AU 3343078A AU 3343078 A AU3343078 A AU 3343078A
Authority
AU
Australia
Prior art keywords
methyl
producing
tetrahydrofolic acid
tetrahydrofolic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU33430/78A
Other versions
AU520715B2 (en
Inventor
Gennari Federico
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIORESEARCH Sas
Original Assignee
BIORESEARCH Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIORESEARCH Sas filed Critical BIORESEARCH Sas
Publication of AU3343078A publication Critical patent/AU3343078A/en
Application granted granted Critical
Publication of AU520715B2 publication Critical patent/AU520715B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU33430/78A 1977-02-22 1978-02-20 PROCESS FOR PRODUCING (d. 1)-5-METHYL-TETRAHYDROFOLIC ACID Expired AU520715B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB7290/77 1977-02-22
GB7290/77A GB1572137A (en) 1977-02-22 1977-02-22 Stable compositions for therapeutic use based on d,1-5-methyltetrahydrofolic acid and its salts

Publications (2)

Publication Number Publication Date
AU3343078A true AU3343078A (en) 1979-08-30
AU520715B2 AU520715B2 (en) 1982-02-25

Family

ID=9830275

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33430/78A Expired AU520715B2 (en) 1977-02-22 1978-02-20 PROCESS FOR PRODUCING (d. 1)-5-METHYL-TETRAHYDROFOLIC ACID

Country Status (32)

Country Link
JP (1) JPS5831353B2 (en)
AR (1) AR215162A1 (en)
AT (1) AT380020B (en)
AU (1) AU520715B2 (en)
BE (1) BE863808A (en)
CA (1) CA1093554A (en)
CH (1) CH635344A5 (en)
CZ (1) CZ279815B6 (en)
DD (1) DD134099A5 (en)
DE (1) DE2807393A1 (en)
DK (1) DK144944C (en)
EG (1) EG13399A (en)
ES (1) ES467153A1 (en)
FI (1) FI67082C (en)
FR (2) FR2381047A1 (en)
GB (1) GB1572137A (en)
GR (1) GR71704B (en)
HU (1) HU179422B (en)
IE (1) IE46402B1 (en)
IL (1) IL54052A (en)
IN (1) IN149574B (en)
LU (1) LU79067A1 (en)
MX (1) MX5288E (en)
NL (1) NL190285C (en)
NO (1) NO147793C (en)
NZ (1) NZ186465A (en)
PL (1) PL118654B1 (en)
PT (1) PT67656B (en)
SE (1) SE437028B (en)
SU (1) SU747427A3 (en)
YU (1) YU40505B (en)
ZA (1) ZA78837B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103214487A (en) * 2013-04-12 2013-07-24 张家港威胜生物医药有限公司 Synthesis of important medical chemical raw material (6S)-5-methyl tetrahydrofolate

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5838285A (en) * 1981-08-25 1983-03-05 Kanegafuchi Chem Ind Co Ltd Preparation of 5-methyl-(6rs)-5,6,7,8-tetrahydro-l-folic acid magnesium salt or its free acid
GB8621268D0 (en) * 1986-09-03 1986-10-08 Univ Strathclyde Separation of substances
IT1229517B (en) * 1989-01-31 1991-09-03 Bioresearch Spa USE OF 5-METHYLTETRAHYDROPHOLIC ACID, OF 5 FORMYLTHETRAHYDROPHOLIC ACID, AND OF THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE SUITABLE FOR BEING EMPLOYED IN THE TREATMENT OF DISORDERS IN THE TREATMENT OF DISORDERS.
IT1229203B (en) * 1989-03-22 1991-07-25 Bioresearch Spa USE OF 5 METHYLTHETRAHYDROPHOLIC ACID, 5 FORMYLTHETRAHYDROPHOLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE ACTIVE IN THE THERAPY OF MENTAL AND ORGANIC DISORDERS.
NL8901432A (en) * 1989-06-06 1991-01-02 Pharmachemie Bv STABLE AQUEOUS FOLINATE SOLUTION AT REFRIGERATOR TEMPERATURE, AND METHOD FOR PREPARING THAT.
CH680731A5 (en) * 1990-04-12 1992-10-30 Sapec Fine Chemicals
US5217974A (en) * 1991-03-29 1993-06-08 Eli Lilly And Company Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity
CH683261A5 (en) * 1991-10-10 1994-02-15 Applied Pharma Res A process for the preparation of Methyltetrahydrofolic in the form (6 (R, S) (-)) N-5 and separation of the active diastereoisomer (6 (S) (-)) N-5) in the form of salts.
CH682665A5 (en) * 1991-10-29 1993-10-29 Sapec Fine Chemicals Process for the purification of crude alkaline earth metal salts from N (5) -methyl-5,6,7,8-tetrahydrofolic acid.
US6162914A (en) * 1998-04-24 2000-12-19 Cerbios-Pharma S.A. Process for the reduction of pterins
CH693905A5 (en) * 1999-04-15 2004-04-15 Eprova Ag Stable crystalline salts of 5-methyl tetrahydrofolic acid.
CH698729B1 (en) * 2007-05-30 2009-10-15 Cerbios Pharma Sa Stable crystalline (6S) -N (5) -methyl-5, 6,7,8-tetrahydrofolic acid.
WO2015193778A1 (en) 2014-06-16 2015-12-23 Mylan Laboratories Ltd. Crystalline form of levomefolate calcium
US20210324176A1 (en) 2018-08-28 2021-10-21 Pmc Organometallix, Inc. Low free 2-mercaptoethanol ester and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL80276C (en) *
GB1293541A (en) * 1969-03-18 1972-10-18 John Alexander Blair Folic acid derivatives
US3856959A (en) * 1972-07-24 1974-12-24 Department Of Health Education Inhibition of leukemia utilizing 5-methyltetrahydrohomofolate
US4148999A (en) * 1977-08-22 1979-04-10 The Government Of The United States Of America Preparation and purification of citrovorum factor
CH649550A5 (en) * 1984-02-09 1985-05-31 Eprova Ag Process for the preparation of alkaline earth metal salts of 5-methyltetrahydrofolic acid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103214487A (en) * 2013-04-12 2013-07-24 张家港威胜生物医药有限公司 Synthesis of important medical chemical raw material (6S)-5-methyl tetrahydrofolate

Also Published As

Publication number Publication date
IE46402B1 (en) 1983-06-01
HU179422B (en) 1982-10-28
BE863808A (en) 1978-05-29
NO147793B (en) 1983-03-07
NO780594L (en) 1978-08-23
FR2385397A1 (en) 1978-10-27
GR71704B (en) 1983-06-21
NZ186465A (en) 1980-10-08
NL190285B (en) 1993-08-02
PL118654B1 (en) 1981-10-31
DD134099A5 (en) 1979-02-07
SU747427A3 (en) 1980-07-23
FI780565A (en) 1978-08-23
NL190285C (en) 1994-01-03
YU40505B (en) 1986-02-28
IL54052A (en) 1981-07-31
FR2385397B1 (en) 1981-07-17
DE2807393C2 (en) 1990-06-13
CZ112978A3 (en) 1995-02-15
FI67082B (en) 1984-09-28
CA1093554A (en) 1981-01-13
SE437028B (en) 1985-02-04
SE7801973L (en) 1978-08-23
CZ279815B6 (en) 1995-07-12
IN149574B (en) 1982-01-30
ZA78837B (en) 1979-09-26
JPS53124297A (en) 1978-10-30
DK76578A (en) 1978-08-23
AU520715B2 (en) 1982-02-25
ATA90378A (en) 1985-08-15
DK144944B (en) 1982-07-12
CH635344A5 (en) 1983-03-31
IE780285L (en) 1978-08-22
FR2381047A1 (en) 1978-09-15
AR215162A1 (en) 1979-09-14
DK144944C (en) 1982-11-29
MX5288E (en) 1983-06-06
EG13399A (en) 1981-12-31
LU79067A1 (en) 1978-06-27
ES467153A1 (en) 1978-11-16
YU37978A (en) 1983-01-21
FI67082C (en) 1985-01-10
FR2381047B1 (en) 1981-07-24
AT380020B (en) 1986-03-25
JPS5831353B2 (en) 1983-07-05
PT67656B (en) 1979-07-19
IL54052A0 (en) 1978-04-30
DE2807393A1 (en) 1978-09-07
NL7801775A (en) 1978-08-24
PT67656A (en) 1978-03-01
NO147793C (en) 1983-06-15
GB1572137A (en) 1980-07-23
PL204747A1 (en) 1979-03-12

Similar Documents

Publication Publication Date Title
GB2041928B (en) Process for producing p-n-alkylbenzoic acid
AU512051B2 (en) Process for preparing 1, 4: , 6-dianhydro-d-glucitol-2-nitrate
AU519107B2 (en) Process for making polyamide
HU178811B (en) Process for producing di-n-propyl-acetic acid
AU520715B2 (en) PROCESS FOR PRODUCING (d. 1)-5-METHYL-TETRAHYDROFOLIC ACID
AU520802B2 (en) Process for making 4-aminohex-5-enoic acid
AU527630B2 (en) Process for producing aryltrifluorethanols
SU913942A3 (en) Process for producing 2,4-diamino-6-pyperidinopyrimidine-3-oxy (its modifications)
HU174059B (en) Process for producing 2,3-dimethyl-penthanale
DE2860031D1 (en) Process for the preparation of 3,4-methylendioxymandelic acid
YU220082A (en) Process for producing 2,3-dicyanopyrazine
AU521884B2 (en) Process for producing cyanuric acid
AU5162879A (en) Process for producing phenoxyalkene derivative
AU512406B2 (en) A process for the production of 2, 9 -dixatricyclo-[4,3,1,03,7] decanes
GB2015517B (en) Process for producing 3,5-dichloro- - methylstyrene
HU175521B (en) Process for producing 2,5-diketoglyconic acid
DE3065329D1 (en) Process for producing 2,3-dihalogenopropionitrile
GB2000499B (en) Process for producing alpha-monochloroacetoacetic acid monomethylamide
AU555140B2 (en) Process for producing 1,2-dichlor-oethane
HU179687B (en) Process for producing 5,6,7,8-- etrahydro-4-bracket-3h-bracket closed-quinasolinones
HU174072B (en) Process for producing new 3,7-disubstituted-ceph-eme-4-carboxylic acid derivatives
YU172279A (en) Process for producing 2-alkoxy-4,6-di-chloro-s-triazines
AU491550B2 (en) Process for preparing. 1, 4-napthalene-dicarboxylic acid esters
HU174708B (en) Process for producing 0,0-dialkyl-s-phtalimino-thiophosphates
HU173661B (en) Process for producing 7-beta-bracket-bracket-2-amino-1,2-dioxy-ethyl-bracket closed-amino-bracket closed-3-methyl-ceph-3-eme-4-carboxylic acid derivatives